With the analysis among 204 patents, we discovered top 51 key players by total patent application. PTC Therapeutics, Inc., Cytogenix, Inc., Biogen MA, Inc. are dominant in this area. They take 36.76% of the total patent filing.
New Jersey, United States
Patent: 38
Texas, United States
Patent: 22
Massachusetts, United States
Patent: 15
QIAGEN Gaithersburg, Inc.
The General Hospital Corp.
Massachusetts, United States
Patent: 11
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 8
Progenics Pharmaceuticals, Inc.
New York, United States
Patent: 6
Helmholtz-Zentrum für Infektionsforschung GmbH
Ionis Pharmaceuticals, Inc.
California, United States
Patent: 6
With the analysis among 14 patents, we discovered top 4 start-ups by total patent application. Skyhawk Therapeutics, Inc., Tempus Labs, Inc., Editforce, Inc. are active in this area.
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 8
Illinois, United States
Patent: 4
Fukuoka-ken, Japan
Patent: 1
Shanghai BDgene Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 1
With the analysis among related 73 patents applied in the last 5 years. We discover 31 most active companies in this area. The fast-growing PTC Therapeutics, Inc., Katholieke Universiteit Leuven, Skyhawk Therapeutics, Inc. take 43.84% of patent filing during this period.
New Jersey, United States
Patent: 16
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 8
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 8
Shanghai Institutes for Biological Sciences CAS
Shanghai Shi, China
Patent: 5
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 4
Illinois, United States
Patent: 4
The General Hospital Corp.
Massachusetts, United States
Patent: 2
Hubei Sheng, China
Patent: 2
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 2
California, United States
Patent: 2
With the analysis among related 73 patents in last 5 years, we discover 23 new entrants. Skyhawk Therapeutics, Inc., Katholieke Universiteit Leuven, Shanghai Institutes for Biological Sciences CAS are the most active new entrants in this area.
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 8
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 8
Shanghai Institutes for Biological Sciences CAS
Shanghai Shi, China
Patent: 5
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 4
Illinois, United States
Patent: 4
Hubei Sheng, China
Patent: 2
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 2
The Board of Trustees of the University of Illinois
Illinois, United States
Patent: 2
California, United States
Patent: 2
Fukuoka-ken, Japan
Patent: 1
With the analysis among 122 patents, we discovered top 26 universities and scientific research institutions by total patent application. Katholieke Universiteit Leuven, The University of North Carolina at Chapel Hill, Albert Einstein College of Medicine, Inc. are dominant in this area. They take 22.13% of the total patent filing.
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 8
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 6
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 6
University of Maryland Baltimore County
The University of Queensland
Queensland, Australia
Patent: 4
University College London
University of Massachusetts
Massachusetts, United States
Patent: 4
Western Australia, Australia
Patent: 4
North Carolina, United States
Patent: 2
Connecticut, United States
Patent: 2